Antioxidant Supplement and Reduction of Metachronous Adenomas of the Large Bowel: a Double Blind Randomized Trial

NCT01437826 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
411
Enrollment
OTHER
Sponsor class

Stopped 50% of eligible patients refused to enter the study

Conditions

Interventions

Sponsor

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

Collaborators